Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Profit After Tax: 2023-2024

Historic Profit After Tax for Pyxis Oncology (PYXS) over the last 2 years, with Dec 2024 value amounting to -$77.3 million.

  • Pyxis Oncology's Profit After Tax fell 3.77% to -$22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$97.1 million, marking a year-over-year change of. This contributed to the annual value of -$77.3 million for FY2024, which is 4.78% down from last year.
  • According to the latest figures from FY2024, Pyxis Oncology's Profit After Tax is -$77.3 million, which was down 4.78% from -$73.8 million recorded in FY2023.
  • Pyxis Oncology's Profit After Tax's 5-year high stood at -$73.8 million during FY2023, with a 5-year trough of -$77.3 million in FY2024.
  • Over the past 2 years, Pyxis Oncology's median Profit After Tax value was -$75.6 million (recorded in 2023), while the average stood at -$75.6 million.
  • Data for Pyxis Oncology's Profit After Tax shows a maximum YoY fell of 4.78% (in 2024) over the last 5 years.
  • Over the past 2 years, Pyxis Oncology's Profit After Tax (Yearly) stood at -$73.8 million in 2023, then decreased by 4.78% to -$77.3 million in 2024.